Molecule of the Week
March 3, 2008
Lisdexamfetamine—trade name Vyvanse—is amphetamine coupled with l-lysine. It is being developed to treat attention-deficit hyperactivity disorder (ADHD) in pediatric patients. It provides controlled release of amphetamine via hydrolysis within the body and decreases the potential for abuse because crushing the capsule does not accelerate its activation.
- Get more information on this molecule from CAS (Chemical Abstracts Service)
- Molecule of the Week archive | About MOTW